Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07457203) titled 'Study on the Drug Interaction Between Buagafuran and Voriconazole' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Beijing Union Pharmaceutical Factory Ltd
Condition:
Drug Drug Interaction (DDI)
Intervention:
Drug: Buagafuran
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: April 2026
Target Sample Size: 18
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07457203
Published by HT Digital Content Servi...